About the Event
Cancer surgery has always been a balancing act between removing cancerous tissue while minimizing the harm to the healthy tissue surrounding it.
CytoVeris has developed TumorMAP, an AI-powered imaging system that delivers real-time cancer tissue visualization, enabling more precise intraoperative surgical decisions and improved patient outcomes.
- Currently targeting 600,000 annual TURBT procedures
- Applies to most other solid tumors
- Works within established workflow delivering results in minutes
- Entering pivotal trials with FDA approval expected in 2024
Join our webinar with CytoVeris President and CEO, Alan Kersey, to learn how TumorMAP enables general surgeons to operate with the precision of the most experienced TURBT specialist.